{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:27:20Z","timestamp":1793662040551,"version":"4.5.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.xphs.2023.04.006","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T10:56:42Z","timestamp":1681469802000},"page":"2276-2284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in The Mouse Eye Following Intravitreal Administration"],"prefix":"10.1016","volume":"112","author":[{"given":"David","family":"Bussing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-0233","authenticated-orcid":false,"given":"Ashwni","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack M.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-6206","authenticated-orcid":false,"given":"Dhaval K","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2023.04.006_bib0001","article-title":"The global economic cost of visual impairment","author":"Gordois","year":"2010","journal-title":"Access Economics Pty Limited for AMD Alliance International"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.006_bib0002","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.xphs.2023.04.006_bib0003","article-title":"4 Bn Wet Age-Related Macular Degeneration Market to 2024 - Rising Prevalence of AMD, Lack of a Specific Treatment, and Increasing Aging Population","year":"2019","journal-title":"GlobeNewswire"},{"key":"10.1016\/j.xphs.2023.04.006_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","article-title":"Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data","volume":"137","author":"del Amo","year":"2015","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.xphs.2023.04.006_bib0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0192623307310955","article-title":"Safety evaluation of ocular drug delivery formulations: techniques and practical considerations","volume":"36","author":"Short","year":"2008","journal-title":"Toxicol Pathol"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.006_bib0006","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1871527315666151110124957","article-title":"Rabbit models of ocular diseases: new relevance for classical Approaches","volume":"15","author":"Zernii","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"12","key":"10.1016\/j.xphs.2023.04.006_bib0007","first-page":"1321","article-title":"Congenital ocular blindness in children, 1945 to 1984","volume":"141","author":"Robinson","year":"1987","journal-title":"Am J Dis Child"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.006_bib0008","first-page":"325","article-title":"Acquired ocular visual impairment in children. 1960-1989","volume":"147","author":"Robinson","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.xphs.2023.04.006_bib0009","doi-asserted-by":"crossref","first-page":"D793","DOI":"10.1093\/nar\/gkn665","article-title":"McKusick's online mendelian inheritance in man (OMIM)","volume":"37","author":"Amberger","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.xphs.2023.04.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183837","article-title":"Mouse models of human ocular disease for translational research","volume":"12","author":"Krebs","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xphs.2023.04.006_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/391384","article-title":"Mouse model resources for vision research","volume":"2011","author":"Won","year":"2011","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.xphs.2023.04.006_bib0012","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-62703-080-9_2","article-title":"Mouse models for studies of retinal degeneration and diseases","volume":"935","author":"Chang","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.006_bib0013","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1017\/S0952523805225075","article-title":"Mouse models of ocular diseases","volume":"22","author":"Chang","year":"2005","journal-title":"Vis Neurosci"},{"key":"10.1016\/j.xphs.2023.04.006_bib0014","series-title":"Herceptin(R). [package insert]","year":"1998"},{"issue":"10","key":"10.1016\/j.xphs.2023.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/dmd.119.087809","article-title":"Effect of size on solid tumor disposition of protein therapeutics","volume":"47","author":"Li","year":"2019","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.xphs.2023.04.006_bib0016","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1167\/iovs.14-16370","article-title":"A novel, real-time, in vivo mouse retinal imaging system","volume":"56","author":"Butler","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.xphs.2023.04.006_bib0017","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0042-6989(01)00146-8","article-title":"Retinal degeneration mutants in the mouse","volume":"42","author":"Chang","year":"2002","journal-title":"Vision Res."},{"issue":"92","key":"10.1016\/j.xphs.2023.04.006_bib0018","first-page":"e51936","article-title":"A highly reproducible and straightforward method to perform in vivo ocular enucleation in the mouse after eye opening","author":"Aerts","year":"2014","journal-title":"J Vis Exp"},{"key":"10.1016\/j.xphs.2023.04.006_bib0019","series-title":"MATLAB. In. Natick, Massachusetts","year":"2020"},{"key":"10.1016\/j.xphs.2023.04.006_bib0020","series-title":"SimBiology. In. Natick, Massachusetts","year":"2020"},{"issue":"1","key":"10.1016\/j.xphs.2023.04.006_bib0021","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1023\/A:1016255124336","article-title":"Applying Bailer's method for AUC confidence intervals to sparse sampling","volume":"12","author":"Nedelman","year":"1995","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2023.04.006_bib0022","unstructured":"Curve Fitting Toolbox. In. Natick, Massachusetts, United States: The MathWorks, Inc.; 2020."},{"issue":"9","key":"10.1016\/j.xphs.2023.04.006_bib0023","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1021\/acs.molpharmaceut.6b00345","article-title":"Contribution of antibody hydrodynamic size to vitreal clearance revealed through rabbit studies using a species-matched fab","volume":"13","author":"Shatz","year":"2016","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.xphs.2023.04.006_bib0024","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.xphs.2023.04.006_bib0025","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1167\/iovs.15-17108","article-title":"Design and pharmacokinetic characterization of novel antibody formats for ocular therapeutics","volume":"56","author":"Gadkar","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.xphs.2023.04.006_bib0026","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/acs.molpharmaceut.7b00164","article-title":"Ocular pharmacokinetics of therapeutic antibodies given by intravitreal injection: estimation of retinal permeabilities using a 3-compartment semi-mechanistic model","volume":"14","author":"Hutton-Smith","year":"2017","journal-title":"Mol Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.006_bib0027","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2005.09.018","article-title":"The pharmacokinetics of rituximab following an intravitreal injection","volume":"82","author":"Kim","year":"2006","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.xphs.2023.04.006_bib0028","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1167\/iovs.16-19204","article-title":"Intraocular pharmacokinetics of intravitreal aflibercept (Eylea) in a rabbit model","volume":"57","author":"Park","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.xphs.2023.04.006_bib0029","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1167\/iovs.09-3569","article-title":"Intravitreal infliximab clearance in a rabbit model: different sampling methods and assay techniques","volume":"50","author":"Giansanti","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.006_bib0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xphs.2023.04.006_bib0031","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/OPTH.S19555","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin(R)) in rabbits","volume":"5","author":"Sinapis","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.xphs.2023.04.006_bib0032","series-title":"WebPlotDigitizer (Version 4.4)","author":"Rohatgi","year":"2020"},{"issue":"10","key":"10.1016\/j.xphs.2023.04.006_bib0033","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":"Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.006_bib0034","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.04-0601","article-title":"Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration","volume":"46","author":"Gaudreault","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.006_bib0035","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1167\/iovs.13-12574","article-title":"Expression of neonatal Fc receptor in the eye","volume":"55","author":"Powner","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xphs.2023.04.006_bib0036","unstructured":"Kim H., Robinson Sb Fau - Csaky KG, Csaky KG. FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. 2009 (1090-0535 (Electronic))."},{"key":"10.1016\/j.xphs.2023.04.006_bib0037","doi-asserted-by":"crossref","unstructured":"van Bilsen K., van Hagen Pm Fau - Bastiaans J., Bastiaans J Fau - van Meurs J.C., van Meurs Jc Fau - Missotten T., Missotten T Fau - Kuijpers RW, Kuijpers Rw Fau - Hooijkaas H, Hooijkaas H Fau - Dingjan GM, Dingjan Gm Fau - Baarsma GS, Baarsma Gs Fau - Dik WA, Dik WA. The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha. 2011 (1468-2079 (Electronic)).","DOI":"10.1136\/bjo.2010.187930"},{"issue":"6","key":"10.1016\/j.xphs.2023.04.006_bib0038","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10928-020-09713-0","article-title":"Development of a physiologically-based pharmacokinetic model for ocular disposition of monoclonal antibodies in rabbits","volume":"47","author":"Bussing","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1016\/j.xphs.2023.04.006_bib0039","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archopht.1989.01070010261033","article-title":"A search for lymphatic drainage of the monkey orbit","volume":"107","author":"McGetrick","year":"1989","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.xphs.2023.04.006_bib0040","first-page":"161","article-title":"[Drainage of the radioactive lymphotropic tracers 198 Au-colloid and 99m Tc-sulfur-colloid from the orbit in rabbits (author's transl)]","volume":"204","author":"Gruntzig","year":"1977","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.xphs.2023.04.006_bib0041","first-page":"713","article-title":"[Studies on the lymph drainage of the eye. 1. Quantitative registration of the lymph drainage from the orbita of the rabbit with radioactive tracers (author's transl)]","volume":"170","author":"Gruntzig","year":"1977","journal-title":"Klin Monbl Augenheilkd"},{"issue":"116","key":"10.1016\/j.xphs.2023.04.006_bib0042","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1208\/s12248-021-00647-0","article-title":"Pharmacokinetics of monoclonal antibody and antibody fragments in the mouse eye following systemic administration","volume":"23","author":"Bussing","year":"2021","journal-title":"AAPS J"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:42:37Z","timestamp":1758361357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0022354923001521"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.04.006","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics of Monoclonal Antibody and Antibody Fragments in The Mouse Eye Following Intravitreal Administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}